コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 azine; the latter removed O acetyls from the O-specific polysaccharide.
2 tiveness of vaccines that exclusively target O-specific polysaccharide.
4 cholera toxin B and A subunits, V. cholerae O-specific polysaccharide and lipopolysaccharide, toxin
5 generation of the serologic response to the O-specific polysaccharide and protection against virulen
6 ffects of K pneumoniae capsule production on O-specific polysaccharide antibody binding and O-specifi
8 specific polysaccharide antibody binding and O-specific polysaccharide antibody-mediated complement d
11 serotype Ogawa, which comprises in part the O-specific polysaccharide component of the native LPS, a
12 lts showed that a vaccine of E. coli O157:H7 O-specific polysaccharide conjugated to recombinant exot
13 carbohydrates, including mannose-containing O-specific polysaccharides derived from bacterial lipopo
14 K pneumoniae bloodstream infection, and peak O-specific polysaccharide-IgG antibody responses in pati
15 dy, we compared plasma antibody responses to O-specific polysaccharide in a cohort of consecutively e
16 intact LPS containing various lengths of the O-specific polysaccharide in the range of 3 and 15 kDa w
17 tical (protective) level of serum IgG to the O-specific polysaccharide (O-SP) domain of Shigella lipo
18 hypothesis that serum IgG antibodies to the O-specific polysaccharide (O-SP) domains of the LPS of t
22 and a clinical trial with a Shigella sonnei O-specific polysaccharide (O-SP)-Pseudomonas aeruginosa
23 0-6, which are specific for Ogawa O-antigen (O-specific polysaccharide; O-SP) of V. cholerae O1, were
24 ing sequence forms the downstream end in the O-specific polysaccharide of both Vibrio cholerae O22 an
25 he case with Shigella, serum IgG against the O-specific polysaccharide of E. coli O157:H7 may confer
26 inst the surface polysaccharide antigen, the O-specific polysaccharide of lipopolysaccharide (LPS), m
28 a dimer of the basic repeating unit from the O-specific polysaccharide of Shigella flexneri 2a, a maj
29 c the terminal hexasaccharide epitope of the O-specific polysaccharide of Vibrio cholerae O1, serotyp
30 S flexneri 2a, 3a, and 6, and S sonnei, and O-specific polysaccharide (OSP) from S flexneri 2a and 3
31 as defined by a rise in serum V. cholerae O1 O-specific polysaccharide (OSP) immunoglobulin A (IgA) o
34 nses among structurally related K pneumoniae O-specific polysaccharide subtypes and to assess the eff
35 he cross-reactivity observed between similar O-specific polysaccharide subtypes in patients with K pn
36 There was cross-reactivity among similar O-specific polysaccharide subtypes, including the O1v1 a
37 non-hyperencapsulated K pneumoniae inhibited O-specific polysaccharide-targeted antibody binding and
38 o assess the effect of capsule production on O-specific polysaccharide-targeted antibody binding and
41 enetically modified strains deficient in the O-specific polysaccharide, we isolated fractions of core
42 prepared by covalently binding E. coli O157 O-specific polysaccharide with Pseudomonas aeruginosa re